Brief: Theriva Biologics Inc Reports Quarterly Loss Per Share Of $0.30

Theriva Biologics

11/05/2023 13:52

May 11 (Reuters) - Theriva Biologics Inc  TOVX.A :
    * THERIVA BIOLOGICS REPORTS FIRST QUARTER 2023 OPERATIONAL
HIGHLIGHTS AND FINANCIAL RESULTS
    * THERIVA BIOLOGICS INC - AS OF MARCH 31, 2023, THERIVA
BIOLOGICS
REPORTS $36.1 MILLION IN CASH, WHICH IS EXPECTED TO PROVIDE
RUNWAY INTO Q3 OF 2024
    * THERIVA BIOLOGICS INC - QTRLY LOSS PER SHARE $0.30

Source text for Eikon:  ID:nGNX2YWGtQ 
Further company coverage:  TOVX.A 

 ((Reuters.Briefs@thomsonreuters.com;;))